Pravastatin manufacturers, plaintiffs announce settlements in US antitrust litigation
By Chris May ( June 11, 2026, 20:08 GMT | Insight) -- Hospitals and independent pharmacies informed a Philadelphia federal judge on Thursday that they have secured settlement agreements with manufacturers of the generic cholesterol drug pravastatin, ending the road toward a bellwether trial in sprawling antitrust litigation against generic drugmakers.Hospitals and independent pharmacies informed a Philadelphia federal judge on Thursday that they had secured settlement agreements with manufacturers of the generic cholesterol drug pravastatin, ending the road toward a bellwether trial in sprawling antitrust litigation against generic drugmakers....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.